retatrutide phase 2 obesity nejm 2023 jastreboff This week's most cited articles: 1. Original Article: Triple–Hormone-Receptor Agonist for — A Trial https://t.co/jNL1GNnHPT #Endocrinology 4 retatrutide myths debunked by

Equally, a peptide pen is not for everyone, and a responsible guide should say so plainly

These results directly challenge the assumption that glucagon receptor activation must necessarily impair weight-loss pharmacotherapy

What are GLP-1 medications and how do they work Medically reviewed by Dr Sultan Linjawi, Endocrinologist & Diabetes Specialist January 2026 GLP-1 medications have become some of the most talked-about treatments in type 2 diabetes and for good reason

Step 4

Weight Loss Medications: They offer a variety of weight loss medications

It improves glycemic control and insulin sensitivity, making it a great option for people who struggle with both obesity and diabetes